NewslettersMammary Cell News miR-218-5p and Doxorubicin Combination Enhances Anticancer Activity in Breast Cancer Cells through Parkin-Dependent Mitophagy Inhibition By Emily Salmini - March 22, 2024 0 Investigators analyzed the role of mitophagy in the treatment of the most common anticancer drug, doxorubicin, in different models of breast cancer. [Cell Death Discovery] Full Article